This Dividend Growth Stock Could Outperform in Q4 BY LUCAS DOWNEY, CONTRIBUTING EDITOR, TRADESMITH DAILY When I find one bullish signal on a stock, I investigate… If I then find two more, I take the setup seriously. That’s what’s unique about today’s opportunity in under-the-radar name Elevance Health (ELV). If you’re unfamiliar with Elevance, they operate medical insurance plans. Formerly known as Anthem Inc., they provide vision, dental and supplemental health care benefits across the United States. On the government side, plans include Medicare and Medicaid. Point is, this is a high-quality business that’s not going anywhere. And after trawling through our TradeSmith data, I was able to spot a few bullish catalysts...a couple of which are teeing up right now. Just like in March, when we were able to identify UnitedHealth Group (UNH) as a cure for rising health care costs, Elevance gives us plenty of reasons to be excited. Let’s explore them now… Three Reasons Elevance Health is a Great Stock to Bet on Now On the technical side, this trade has something for both momentum-chasers and mean-reversion traders. Let’s start with the latter crowd. On Oct. 8, something rare occurred. Elevance Health shares dropped seven days in a row: 
Using the eyeball test, this downtrend may appear as a worrying sign. But don’t fall for it! Because this is where being armed with historical data shines. Going back to 2002, ELV shares have only had a seven-day down streak 10 times...making it a very rare event. And here’s what happened next: - A month later, the shares were up an average of 4%
- And two months later spelled an average gain of 7.08%.
Those one-month and two-month gains numbers would be huge long-term market outperformers, so take note. And to top it all off, the positive win rates for these events are all well above 50%. Again, investing is all about stacking the odds in our favor. Knowing that ELV tends to rebound strongly after such a down streak is a great way to do that. This is reason number 1 to get excited about Elevance Health stock. But if this pure reversion signal doesn’t excite you, we’ve got more! Reason number 2 to jump on shares of ELV comes down to a powerful seasonal tailwind. By using TradeSmith’s Seasonality tool, I was able to spot one of the strongest seasonal patterns that jumped off the page. Over 15 years of data, shares of ELV have jumped an average of 10.13% over the nearly three-month period from Oct. 7–Dec. 30. Just as impressive is that ELV was up 93% of the time: 
The bullish Q4 setup for the S&P 500 we highlighted last week is coming into focus here. The market’s rising tide is set to lift multiple boats into year-end. Let’s do a quick recap to see where things stand. First, we have an oversold bounce favoring ELV. Second, we have a powerful seasonal pattern starting right now. Then there’s another signal that’s qualitative in nature and puts Elevance in the all-star league of stocks... Reason number 3 to buy shares of Elevance Health comes down to the staggering dividend growth. Few things excite me more than growing dividends. But I’ll make an exception when we’re discussing an oversold + seasonal opportunity! Growing dividends represents a healthy business that rewards shareholders. Few companies fall into this bucket. And Elevance Health has been steadily increasing its dividend payout yearly. In 2017, annual dividend payments amounted to $2.70 per share. Analysts expect that annual payout to hit $6.52 for the full year 2024. That would be 141% dividend growth in seven years. Folks, that’s one healthy trend: 
Look, there are thousands of stocks vying for your attention every single day. Truthfully, only a handful are worthy of investigation. Utilizing an evidence-based approach to sort through them is how you not only win, but how you find tomorrow’s leading stocks today. If you’re not using software tools like TradeSmith to uncover hidden situations like ELV... you’re missing out. Here’s wishing you good health in 2025...and even better wealth! Regards, Lucas Downey
Contributing Editor, TradeSmith Daily Note from Ashley Cassell, Managing Editor, TradeSmith Daily: Here’s another special situation for your radar… Louis Navellier from our corporate partner InvestorPlace just issued an unusual call on AI stocks. In short, he thinks next-generation AI could be an even more powerful investing theme than the first wave of AI plays – chipmakers, ChatGPT and Big Tech stocks. Here’s Louis: Just as the second generation of tech stocks after the dot-com era went on to run laps around the first-generation group of tech stocks, we’ll see the same thing happen with AI. This will be the Real AI Boom: companies that use generative AI to reinvent or automate some of the oldest business models around. This, in turn, will launch the kind of transformational change we only see once every 25 years. And these changes will roll out across society and reshape America on the same historic scale we saw in the late ’90s. Louis has a free briefing for you on the investing opportunity here. Watch now to learn why he sees such huge potential in six specific companies... and hear about the quantitative stock-picking system that helped find them. | 
0 Response to "This Dividend Growth Stock Could Outperform in Q4"
Post a Comment